Dr. David Weill has served on the TransMedics Board since April 2019.
Since 2016 he has been Principal of the Weill Consulting Group, a biomedical consulting group focusing on organ transplantation and lung disease, and has been involved in the transplant and advanced lung disease fields for over 20 years.
He served as Director of the Lung and Heart-Lung Transplant Program at Stanford University Medical Center from 2005 until 2016 and is the former Director of the Stanford Center for Advanced Lung Diseases; he holds a B.A. and M.D. from Tulane University.